| Gene symbol | AR | Synonyms | AIS, AR8, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq12 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | androgen receptor | ||||
| GTO ID | GTC1481 |
| Trial ID | NCT02144051 |
| Disease | Advanced Solid Tumor |
| Altered gene | AR |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | AZD5312|ISIS 560131|ARRx |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I, Open-Label, Multicentre Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD5312 in Patients With Advanced Solid Tumours Where the Androgen Receptor Pathway is a Potential Factor |
| Year | 2014 |
| Country | United Kingdom|United States |
| Company sponsor | AstraZeneca |
| Other ID(s) | D5860C00001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||